Bio-Techne Ties $0.08 Dividend to Merck KGaA Deal Timing
MINNEAPOLIS – – November 03, 2026 -- Bio-Techne Corporation (NASDAQ: TECH) will pay a quarterly dividend of $0.08 per share only if its pending transaction with Merck KGaA, Darmstadt, Germany has not closed by the close of business on November 13, 2026.
Dividend payable November 23 to holders of record on November 13
The Board of Directors declared the payout for the quarter ended September 30, 2026. Payment is due November 23, 2026, to all common shareholders of record at the close of business on November 13, 2026. The record date doubles as the deadline for the deal condition. If the Merck KGaA transaction closes on or before that date, the dividend will not be paid.
Board will review future dividends quarterly
The board said it will consider future cash dividends on a quarterly basis, as applicable. The company gave no commitment on payouts beyond the current declaration.
